0001237899-12-000063.txt : 20120727
0001237899-12-000063.hdr.sgml : 20120727
20120727111048
ACCESSION NUMBER: 0001237899-12-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120725
FILED AS OF DATE: 20120727
DATE AS OF CHANGE: 20120727
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powchik Peter
CENTRAL INDEX KEY: 0001377247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 12989356
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2012-07-25
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001377247
Powchik Peter
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Clinical Development & Reg
Common Stock
2012-07-25
4
M
0
15000.0
16.8
A
30144.0
D
Common Stock
2012-07-25
4
F
0
1987.0
126.76
D
28157.0
D
Common Stock
2012-07-25
4
F
0
5994.0
126.76
D
22163.0
D
Common Stock
2012-07-26
4
S
0
4519.0
130.4
D
17644.0
D
Common Stock
2012-07-26
4
S
0
2500.0
131.07
D
15144.0
D
Common Stock
1532.0
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
16.8
2012-07-25
4
M
0
15000.0
D
2011-12-17
2018-12-17
Common Stock
15000.0
15000.0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 4,519 shares of Company stock on July 26, 2012 at prices ranging from $130.21 to $130.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 26, 2012 at each separate price.
Represents volume-weighted average price of sales of 2,500 shares of Company stock on July 26, 2012 at prices ranging from $131.05 to $131.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 26, 2012 at each separate price.
On December 17, 2008, the reporting person was granted an option to purchase 30,000 shares of Common Stock. The option was eligible to vest, partially or in full, on December 31, 2011, based on the extent to which the company satisfied certain performance criteria. The performance criteria were met and the option vested as to all shares.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Peter Powchik
2012-07-27